http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35670777

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
issn 2045-2322
issueIdentifier 1
pageRange 8054-
publicationName Scientific Reports
startingPage 8054
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_82ae0d15c258a1611e08c28d1a3430a9
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_fe9f41007d9c1440c48753debd58b30c
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_84599dac9f3158cbcae1c2225c13f5d4
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_68a65e0f35f603a2ce5a36d6b4aa808e
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_df0b6c7c72fa1e4bb7b45d55116672fd
bibliographicCitation Velentza L, Wickström M, Kogner P, Ohlsson C, Zaman F, Sävendahl L. Pharmacological inhibition of BCL-2 with the FDA-approved drug venetoclax impairs longitudinal bone growth. Sci Rep. 2023 May 17;13(1):8054. PMID: 37198212; PMCID: PMC10192431.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d57db4babe53adf0fc711aa064cfa5a3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_afd1b206db3935358de61809b3639a83
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1b625735a1db8b65768b348a4c25dbed
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a821b4f5bfde0cdd3ea545436b37fd8f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5e01cddd7a6fc7b9b768948a29b85818
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_79533f9b7d428d61cbd6aaa4413c536c
date 2023-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC10192431
https://doi.org/10.1038/s41598-023-34965-4
https://pubmed.ncbi.nlm.nih.gov/37198212
isPartOf https://portal.issn.org/resource/ISSN/2045-2322
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/39356
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Pharmacological inhibition of BCL-2 with the FDA-approved drug venetoclax impairs longitudinal bone growth
discusses http://id.nlm.nih.gov/mesh/M000614617
http://id.nlm.nih.gov/mesh/M0028673
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D001846
http://id.nlm.nih.gov/mesh/D019902Q000378
hasSubjectTerm http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D051381
http://id.nlm.nih.gov/mesh/D051379
http://id.nlm.nih.gov/mesh/D006132Q000378
http://id.nlm.nih.gov/mesh/D002356Q000378
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D019253Q000378
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10364
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4f3366af2ce1555e259faab86aad3bef
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8111
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49846579

Total number of triples: 44.